NUVARING

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NUVARING contains a combination of these active pharmaceutical ingredients (APIs):

1 Etonogestrel UNII 304GTH6RNH - ETONOGESTREL

Etonogestrel is the biologically active metabolite of desogestrel, a progestagen widely used in OCs. It is structurally derived from 19-nortestosterone and binds with high affinity to progesterone receptors in the target organs. The contraceptive effect of etonogestrel is primarily achieved by inhibition of ovulation. Read about Etonogestrel

2 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02BB01	Vaginal ring with progestogen and estrogen	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02B Contraceptives for topical use → G02BB Intravaginal contraceptives
Discover more medicines within G02BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527302401176313, 527319060019403, 527319060019503
Country: CA	Health Products and Food Branch	Identifier(s): 02253186
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.317-08-03
Country: EE	Ravimiamet	Identifier(s): 1138621, 1138632
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 5717756, 64570
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 005369, 005436
Country: FR	Base de données publique des médicaments	Identifier(s): 62148867
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 153646, 374065, 381569
Country: IE	Health Products Regulatory Authority	Identifier(s): 36003
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4937
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015653, 1015654, 1058012, 1083147, 1083148, 1093332
Country: MT	Medicines Authority	Identifier(s): MA031/02201
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 422M2003
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 72885
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100180329, 100429496, 100446508, 100447123
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68335001, W68335002, W68335003, W68335004
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337305
Country: US	FDA, National Drug Code	Identifier(s): 0052-0273, 50090-1008
Country: ZA	Health Products Regulatory Authority	Identifier(s): 38/34/0171